The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy

Epilepsia

Volumn 55, Issue 8, 2014, Pages 1229-1234

  Vajda, Frank J E ^a   O'Brien, Terrence ^a   Lander, Cecilie ^b   Graham, Janet ^a   Eadie, Mervyn ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antiepileptic drugs; Lamotrigine; Levetiracetam; Pregnancy; Seizures; Topiramate

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; PATIENT SATISFACTION; POLYPHARMACY; PREGNANT WOMAN; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

ANTIEPILEPTIC DRUGS; LAMOTRIGINE; LEVETIRACETAM; PREGNANCY; SEIZURES; TOPIRAMATE;

ANTICONVULSANTS; FEMALE; FRUCTOSE; HUMANS; PIRACETAM; PREGNANCY; REGISTRIES; SEIZURES; TREATMENT OUTCOME; TRIAZINES; VICTORIA;

EID: 84906101474     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12711     Document Type: Article

References (23)

1. Talati R, Scholle JM, Phung OJ, et al. Effectiveness and safety of antiepileptic medications in patients with epilepsy. Comparative effectiveness review No.40. AHRQ Publication No. 11 (12) -EHC082-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
2. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000-1015.
3. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016-1026.
4. Vajda FJE, Lander CM, Hitchcock A, et al. Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences. J Clin Neurosci 2007; 14: 611-617.
5. Vajda FJE, Horgan D, Hollingworth S, et al. Changing patterns of antiepileptic drug use in pregnant Australian women. Aust J NZ Obstet Gynaec 2012; 52: 49-53.
6. Bobo WV, Davis RL, Toh S, et al. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation study. Paediatr Perinat Epidemiol 2012; 26: 578-588.
7. Man S-L, Petersen I, Thompson M, et al. Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS ONE 2012; 7: e52339.
8. Tomson T, Battino D,. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012; 11: 803-813.
9. Holmes LB, Hernandez-Diaz S,. Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol 2012; 94: 599-606.
10. Holmes LB, Mittendorf R, Shen A, et al. Fetal effects of anticonvulsant polytherapies. Arch Neurol 2011; 68: 1275-1281.
11. Molgaard-Nielsen D, Hviid A,. Newer-generation antiepileptic drugs and the risk of major birth defects. J Am Med Assoc 2011; 305: 1996-2002.
12. Vajda FJE, Graham J, Hitchcock AA, et al. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010; 19: 558-561.
13. Vajda FJE, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 2008; 49: 172-175.
14. Harden C, Hopp J, Ting TY, et al. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): 1. Obstetrical complications and changes in seizure frequency. Epilepsia 2009; 50: 1229-1236.
15. Knight AH, Rhind EG,. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975; 16: 99-110.
16. Schmidt D,. The effect of pregnancy on the natural history of epilepsy: review of the literature. In, Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D, (Eds) Epilepsy, pregnancy, and the child. New York, NY: Raven Press, 1982: 3-14.
17. Pirie DAJ, Wattar BHA, Pirie AM, et al. Effect of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2014; 172: 26-31.
18. Reisinger TL, Newman M, Loring DW, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 2013; 20: 13-18.
19. Thomas SV, Syan U, Devi JS,. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia 2011; 53: e85-e88.
20. Battino D, Tomson T, Bonizzoni E, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 2013; 54: 1621-1627.
21. Sabers A, Petrenaite V,. Seizure frequency in pregnant women treated with lamotrigine monotherapy. Epilepsia 2009; 50: 2163-2166.
22. Mahwinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy. Results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013; 80: 401-405.
23. Shallcross R, Bromley RL, Irwin B, et al. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011; 76: 383-389.